CAI Stock Recent News

Caris Life Sciences has filed to raise $100 million in a U.S. IPO, although the final amount may be higher. CAI operates in the precision medicine information market for the treatment of cancer and wants to ultimately expand into other disease conditions. The company faces significant competition, high debt, payer concentration risk.